Snowball logo
logo
0418

InBody Co.Ltd

041830 KQ
66,200.00-1,200.00  (1.78%)
Estimate
Beta
0.687
Growth
Revenue, YoY
23.14%
Net income, YoY
133.27%
FCF, YoY
35%
Forecast
P/E (FWD)
16.6
EPS (FWD)
3,982
Dividends
Dividend yield
0.91%
Annual payout
600.00
Next ex. div date
March 30, 27
Payout
16.46%
Div.growth, 5y
23.36%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
041830
ISIN
KR7041830001
Country
South Korea
Sector (GICS)
Healthcare
InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

Frequently asked questions

What sector does InBody Co.Ltd (041830) operate in?

InBody Co.Ltd belongs to the Healthcare sector and operates in the Healthcare Equipment & Supplies industry.

What is InBody Co.Ltd (041830) current stock price?

As of the latest data, InBody Co.Ltd stock price is ₩66,200, with a previous close of ₩67,400. InBody Co.Ltd lost -₩1,200 in the last trading session, representing a -1.78% loss.

What is InBody Co.Ltd (041830) current market capitalization?

InBody Co.Ltd market cap is approximately 892.55 billion.

Does InBody Co.Ltd (041830) pay dividends?

Yes. InBody Co.Ltd pays annual dividends with an annualized yield of 0.91% and an estimated annual payout of ₩600 per share.

When is the next ex-dividend date for InBody Co.Ltd (041830)?

The next ex-dividend date is scheduled for March 30, 2027.

What is InBody Co.Ltd (041830) beta (volatility) score?

InBody Co.Ltd has a beta of 0.687, indicating lower volatility than the overall market.